A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months – working in all subsets of the most common type of breast cancer. …read more
A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months – working in all subsets of the most common type of breast cancer. …read more
Comments are closed.
Nice posts! 🙂
___
Sanny
http://afcmarseille.com